MedPath

The construction of an overall evaluation method for the clinical efficacy of TCM and western medicine in co-constructing parallel medical records

Phase 1
Not yet recruiting
Conditions
precancerous gastric lesions
Registration Number
ITMCTR1900002299
Lead Sponsor
Beijing Institute of Traditional Chinese Medicine Clinical Epidemiology and Evidence-Based Medicine Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with precancerous lesions of the stomach that conform to the consensus opinion on chronic gastritis in China (2017, Shanghai) and the Kyoto global consensus opinion on helicobacter pylori gastritis; At the same time, the patient had the gastroscope and pathology of the first-grade hospital within three months, and the pathological report was clearly one of atrophy, intestinal metaplasia and epithelial neoplasia (dysplasia);
(2) aged between 30 and 70 years;
(3) The patient or family member knows the content of the study and voluntarily signs the informed consent.

Exclusion Criteria

1. Pregnancy or pregnancy preparation;
2. With acute cerebral vascular disease;
3. Surgery, major posttraumatic;
4. Patients with known malignant tumors, severe chronic heart, liver, renal insufficiency, and immune deficiencyhigh grade epithelial neoplasia and more severe cases;
5. The patient has a major mental illness or has difficulty controlling his behavior;
6. The patient can not read, can not understand the informed consent or can not sign the informed consent by themselves.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.